Getinge AB ser. B (ST:GETI-B) — Market Cap & Net Worth
Market Cap & Net Worth: Getinge AB ser. B (GETI-B)
Getinge AB ser. B (ST:GETI-B) has a market capitalization of $5.02 Billion (Skr46.65 Billion) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #3584 globally and #54 in its home market, demonstrating a -6.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Getinge AB ser. B's stock price Skr183.55 by its total outstanding shares 254152373 (254.15 Million). Analyse how efficiently does Getinge AB ser. B generate cash to see how efficiently the company converts income to cash.
Getinge AB ser. B Market Cap History: 2015 to 2026
Getinge AB ser. B's market capitalization history from 2015 to 2026. Data shows growth from $3.68 Billion to $5.02 Billion (3.59% CAGR).
Index Memberships
Getinge AB ser. B is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
STOXX Europe Mid 200 EUR Price
MCXP
|
$1.51 Trillion | 0.33% | #72 of 157 |
|
STOXX Europe Mid 200 EUR Net Return
MCXR
|
$1.51 Trillion | 0.33% | #72 of 157 |
Weight: Getinge AB ser. B's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Getinge AB ser. B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Getinge AB ser. B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
Getinge AB ser. B's market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.65x
Getinge AB ser. B's market cap is 2.65 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.46 Billion | $29.76 Billion | $1.19 Billion | 0.08x | 2.07x |
| 2017 | $2.94 Billion | $22.50 Billion | $1.38 Billion | 0.13x | 2.14x |
| 2018 | $2.01 Billion | $24.17 Billion | -$967.00 Million | 0.08x | N/A |
| 2019 | $4.40 Billion | $26.56 Billion | $1.22 Billion | 0.17x | 3.60x |
| 2020 | $4.94 Billion | $29.82 Billion | $3.24 Billion | 0.17x | 1.53x |
| 2021 | $10.28 Billion | $27.05 Billion | $2.97 Billion | 0.38x | 3.46x |
| 2022 | $5.71 Billion | $28.29 Billion | $2.49 Billion | 0.20x | 2.29x |
| 2023 | $6.02 Billion | $31.83 Billion | $2.41 Billion | 0.19x | 2.50x |
| 2024 | $4.97 Billion | $34.76 Billion | $1.64 Billion | 0.14x | 3.03x |
| 2025 | $5.98 Billion | $34.97 Billion | $2.26 Billion | 0.17x | 2.65x |
Competitor Companies of GETI-B by Market Capitalization
Companies near Getinge AB ser. B in the global market cap rankings as of May 4, 2026.
Key companies related to Getinge AB ser. B by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Getinge AB ser. B Historical Marketcap From 2015 to 2026
Between 2015 and today, Getinge AB ser. B's market cap moved from $3.68 Billion to $ 5.02 Billion, with a yearly change of 3.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr5.02 Billion | -16.11% |
| 2025 | Skr5.98 Billion | +20.52% |
| 2024 | Skr4.97 Billion | -17.49% |
| 2023 | Skr6.02 Billion | +5.44% |
| 2022 | Skr5.71 Billion | -44.49% |
| 2021 | Skr10.28 Billion | +107.98% |
| 2020 | Skr4.94 Billion | +12.24% |
| 2019 | Skr4.40 Billion | +119.54% |
| 2018 | Skr2.01 Billion | -31.72% |
| 2017 | Skr2.94 Billion | +19.29% |
| 2016 | Skr2.46 Billion | -33.00% |
| 2015 | Skr3.68 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Getinge AB ser. B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.02 Billion USD |
| MoneyControl | $5.02 Billion USD |
| MarketWatch | $5.02 Billion USD |
| marketcap.company | $5.02 Billion USD |
| Reuters | $5.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solu… Read more